← Back to All Stocks

Geron Corporation (GERN) Analysis

Generated on: 2025-07-16 15:23:53 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$1.28
Predicted Price
$1.55
Expected Return
15.44%
Confidence Score
0.77
RSI (14)
29.32 (buy)
MACD
-0.05
Volume
1,930,686
Float Shares
537,813,355
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
251

GERN

Geron Corporation
15.44%
Price: $1.28
Confidence: 0.77
News
RSI Buy
Last updated: 2025-07-16 15:23:53

Technical Analysis

RSI: 29.32 (buy)
MACD: -0.05
Technical Analysis Graph

Risk Analysis

Volatility
65.73%
Max Drawdown
-75.31%
Beta
1.0
Risk Score
76.4

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Geron Presents Positive RYTELO Data for LR-MDS at ASCO & EHA, Highlights Efficacy, Myelofibrosis Program Progress
Insider Monkey - 2025-07-15 12:58
Geron Corporation (NASDAQ:GERN) is one of the best low priced pharma stocks to buy now. Earlier on May 28, Geron Corporation presented new data on RYTELO (imetelstat) at the 2025 American Society of Clinical Oncology/ASCO Annual Meeting and the European Hematology Association/EHA 2025 Congress. These presentations underscored the efficacy and safety of RYTELO across patients […]

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.